Medicina,
Год журнала:
2022,
Номер
58(3), С. 419 - 419
Опубликована: Март 12, 2022
Dyspnea,
shortness
of
breath,
and
chest
pain
are
frequent
symptoms
post-COVID
syndrome
(PCS).
These
unrelated
to
organ
damage
in
most
patients
after
mild
acute
COVID
infection.
Hyperventilation
has
been
identified
as
a
cause
exercise-induced
dyspnea
PCS.
Since
there
is
broad
overlap
symptomatology
with
myalgic
encephalomyelitis/chronic
fatigue
(ME/CFS),
causes
for
potential
consequences
can
be
deduced
by
stringent
application
assumptions
made
ME/CFS
our
recent
review
papers.
One
the
first
stimuli
respiration
exercise
caused
metabolic
feedback
via
skeletal
muscle
afferents.
PCS,
which
occurs
early
on
during
exercise,
arise
from
combined
disturbance
poor
energetic
situation
autonomic
dysfunction
(overshooting
respiratory
response),
both
found
ME/CFS.
The
exaggerated
response
aggravating
does
not
only
limit
ability
but
further
impairs
muscular
situation:
one
buffering
mechanisms
alkalosis
proton
shift
intracellular
extracellular
space
sodium–proton-exchanger
subtype
1
(NHE1),
thereby
loading
cells
sodium.
This
adds
two
other
sodium
already
operative,
namely
glycolytic
metabolism
(intracellular
acidosis)
impaired
Na+/K+ATPase
activity.
High
unfavorable
effects
mitochondrial
calcium
sodium–calcium-exchangers
(NCX).
Mitochondrial
overload
high
reversing
transport
mode
NCX
import
key
driver
chronification.
Prevention
hyperventilation
therapeutic
keeping
below
threshold
where
occurs.
BMJ,
Год журнала:
2021,
Номер
unknown, С. n1648 - n1648
Опубликована: Июль 26, 2021
Since
its
emergence
in
Wuhan,
China,
covid-19
has
spread
and
had
a
profound
effect
on
the
lives
health
of
people
around
globe.
As
4
July
2021,
more
than
183
million
confirmed
cases
been
recorded
worldwide,
3.97
deaths.
Recent
evidence
shown
that
range
persistent
symptoms
can
remain
long
after
acute
SARS-CoV-2
infection,
this
condition
is
now
coined
covid
by
recognized
research
institutes.
Studies
have
affect
whole
spectrum
with
covid-19,
from
those
very
mild
disease
to
most
severe
forms.
Like
involve
multiple
organs
many
systems
including,
but
not
limited
to,
respiratory,
cardiovascular,
neurological,
gastrointestinal,
musculoskeletal
systems.
The
include
fatigue,
dyspnea,
cardiac
abnormalities,
cognitive
impairment,
sleep
disturbances,
post-traumatic
stress
disorder,
muscle
pain,
concentration
problems,
headache.
This
review
summarizes
studies
term
effects
hospitalized
non-hospitalized
patients
describes
they
endure.
Risk
factors
for
possible
therapeutic
options
are
also
discussed.
Annals of Medicine,
Год журнала:
2022,
Номер
54(1), С. 1473 - 1487
Опубликована: Май 20, 2022
After
almost
2
years
of
fighting
against
SARS-CoV-2
pandemic,
the
number
patients
enduring
persistent
symptoms
long
after
acute
infection
is
a
matter
concern.
This
set
was
referred
to
as
"long
COVID",
and
it
defined
more
recently
"Post
COVID-19
condition"
by
World
health
Organization
(WHO).
Although
studies
have
revealed
that
COVID
can
manifest
whatever
severity
inaugural
illness,
underlying
pathophysiology
still
enigmatic.To
conduct
comprehensive
review
address
putative
persisting
COVID.We
searched
11
bibliographic
databases
(Cochrane
Library,
JBI
EBP
Database,
Medline,
Embase,
PsycInfo,
CINHAL,
Ovid
Nursing
Journals@Ovid,
SciLit,
EuropePMC,
CoronaCentral).
We
selected
put
forward
hypotheses
on
pathophysiology,
well
those
encompassed
in
their
research
investigation.A
total
98
articles
were
included
systematic
review,
54
which
exclusively
addressed
while
44
involved
patients.
Studies
displayed
heterogeneity
with
respect
initial
timing
analysis,
or
presence
control
group.
likely
results
from
long-term
organ
damage
due
acute-phase
infection,
specific
mechanisms
following
illness
could
contribute
later
possibly
affecting
many
organs.
As
such,
autonomic
nervous
system
account
for
without
clear
evidence
damage.
Immune
dysregulation,
auto-immunity,
endothelial
dysfunction,
occult
viral
persistence,
coagulation
activation
are
main
pathophysiological
so
far.Evidence
why
occur
limited,
available
heterogeneous.
Apart
damage,
hints
suggest
be
symptoms.
KEY
MESSAGESLong-COVID
multisystem
disease
develops
regardless
severity.
Its
clinical
spectrum
comprises
wide
range
symptoms.The
its
unclear.
phase
accounts
symptoms,
long-lasting
inflammatory
been
proposed,
well.Existing
involving
Long-COVID
highly
heterogeneous,
they
include
various
levels
different
time
frame
well.
Brain Behavior and Immunity,
Год журнала:
2021,
Номер
97, С. 328 - 348
Опубликована: Июль 30, 2021
It
has
become
evident
that
coronavirus
disease
2019
(COVID-19)
a
multi-organ
pathology
includes
the
brain
and
nervous
system.
Several
studies
have
also
reported
acute
psychiatric
symptoms
in
COVID-19
patients.
An
increasing
number
of
are
suggesting
deficits
may
persist
after
recovery
from
primary
infection.
In
current
systematic
review,
we
provide
an
overview
available
evidence
supply
information
on
potential
risk
factors
underlying
biological
mechanisms
behind
such
sequelae.
We
performed
search
for
sequelae
patients
using
databases
PubMed
Embase.
Included
all
contained
follow-up
period
provided
quantitative
measures
mental
health.
The
was
June
4th
2021.
1725
unique
were
identified.
Of
these,
66
met
inclusion
criteria
included.
Time
to
ranged
immediately
hospital
discharge
up
7
months
discharge,
participants
spanned
3
266,586
participants.
Forty
anxiety
and/or
depression,
20
symptoms-
or
diagnoses
post-traumatic
stress
disorder
(PTSD),
27
cognitive
deficits,
32
articles
found
fatigue
at
follow-up,
sleep
disturbances
23
studies.
Highlighted
severity,
duration
symptoms,
female
sex.
One
study
showed
abnormalities
correlating
with
several
inflammatory
markers
correlate
symptoms.
Overall,
results
this
review
suggest
survivors
but
generally
improve
over
time.
Biochemical Journal,
Год журнала:
2022,
Номер
479(4), С. 537 - 559
Опубликована: Фев. 23, 2022
Post-acute
sequelae
of
COVID
(PASC),
usually
referred
to
as
‘Long
COVID’
(a
phenotype
COVID-19),
is
a
relatively
frequent
consequence
SARS-CoV-2
infection,
in
which
symptoms
such
breathlessness,
fatigue,
‘brain
fog’,
tissue
damage,
inflammation,
and
coagulopathies
(dysfunctions
the
blood
coagulation
system)
persist
long
after
initial
infection.
It
bears
similarities
other
post-viral
syndromes,
myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS).
Many
regulatory
health
bodies
still
do
not
recognize
this
separate
disease
entity,
refer
it
under
broad
terminology
‘COVID’,
although
its
demographics
are
quite
different
from
those
acute
COVID-19.
A
few
years
ago,
we
discovered
that
fibrinogen
can
clot
into
an
anomalous
‘amyloid’
form
fibrin
(like
β-rich
amyloids
prions)
resistant
proteolysis
(fibrinolysis).
The
result,
strongly
manifested
platelet-poor
plasma
(PPP)
individuals
with
Long
COVID,
extensive
amyloid
microclots
persist,
entrap
proteins,
may
lead
production
various
autoantibodies.
These
more-or-less
easily
measured
PPP
stain
thioflavin
T
simple
fluorescence
microscope.
Although
multifarious,
here
argue
ability
these
(fibrinaloids)
block
up
capillaries,
thus
limit
passage
red
cells
hence
O2
exchange,
actually
underpin
majority
symptoms.
Consistent
this,
preliminary
report,
has
been
shown
suitable
closely
monitored
‘triple’
anticoagulant
therapy
leads
removal
also
removes
Fibrin
represent
novel
potentially
important
target
for
both
understanding
treatment
related
disorders.
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Июль 5, 2023
Abstract
Transient
receptor
potential
(TRP)
channels
are
sensors
for
a
variety
of
cellular
and
environmental
signals.
Mammals
express
total
28
different
TRP
channel
proteins,
which
can
be
divided
into
seven
subfamilies
based
on
amino
acid
sequence
homology:
TRPA
(Ankyrin),
TRPC
(Canonical),
TRPM
(Melastatin),
TRPML
(Mucolipin),
TRPN
(NO-mechano-potential,
NOMP),
TRPP
(Polycystin),
TRPV
(Vanilloid).
They
class
ion
found
in
numerous
tissues
cell
types
permeable
to
wide
range
cations
such
as
Ca
2+
,
Mg
Na
+
K
others.
responsible
various
sensory
responses
including
heat,
cold,
pain,
stress,
vision
taste
activated
by
number
stimuli.
Their
predominantly
location
the
surface,
their
interaction
with
physiological
signaling
pathways,
unique
crystal
structure
make
TRPs
attractive
drug
targets
implicate
them
treatment
diseases.
Here,
we
review
history
discovery,
summarize
structures
functions
family,
highlight
current
understanding
role
pathogenesis
human
disease.
Most
importantly,
describe
channel-related
therapeutic
interventions
diseases
limitations
targeting
clinical
applications.
People
living
with
long
COVID
describe
a
high
symptom
burden,
and
more
detailed
assessment
is
needed
to
inform
rehabilitation
recommendations.
The
objectives
were
use
validated
questionnaires
measure
the
severity
of
fatigue
compare
this
normative
data
thresholds
for
clinical
relevance
in
other
diseases;
impact
postexertional
malaise
(PEM);
assess
symptoms
dysfunctional
breathing,
self-reported
physical
activity,
health-related
quality
life.
Frontiers in Medicine,
Год журнала:
2023,
Номер
10
Опубликована: Июнь 2, 2023
Some
patients
remain
unwell
for
months
after
"recovering"
from
acute
COVID-19.
They
develop
persistent
fatigue,
cognitive
problems,
headaches,
disrupted
sleep,
myalgias
and
arthralgias,
post-exertional
malaise,
orthostatic
intolerance
other
symptoms
that
greatly
interfere
with
their
ability
to
function
can
leave
some
people
housebound
disabled.
The
illness
(Long
COVID)
is
similar
myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS)
as
well
persisting
illnesses
follow
a
wide
variety
of
infectious
agents
following
major
traumatic
injury.
Together,
these
are
projected
cost
the
U.S.
trillions
dollars.
In
this
review,
we
first
compare
ME/CFS
Long
COVID,
noting
considerable
similarities
few
differences.
We
then
in
extensive
detail
underlying
pathophysiology
two
conditions,
focusing
on
abnormalities
central
autonomic
nervous
system,
lungs,
heart,
vasculature,
immune
gut
microbiome,
energy
metabolism
redox
balance.
This
comparison
highlights
how
strong
evidence
each
abnormality,
illness,
helps
set
priorities
future
investigation.
review
provides
current
road
map
literature
biology
both
illnesses.
Reviews in Medical Virology,
Год журнала:
2021,
Номер
32(4)
Опубликована: Дек. 9, 2021
Summary
The
effects
of
coronavirus
disease
2019
(COVID‐19),
a
highly
transmissible
infectious
respiratory
that
has
initiated
an
ongoing
pandemic
since
early
2020,
do
not
always
end
in
the
acute
phase.
Depending
on
study
referred,
about
10%–30%
(or
more)
COVID‐19
survivors
may
develop
long‐COVID
or
post‐COVID‐19
syndrome
(PCS),
characterised
by
persistent
symptoms
(most
commonly
fatigue,
dyspnoea,
and
cognitive
impairments)
lasting
for
3
months
more
after
COVID‐19.
While
pathophysiological
mechanisms
PCS
have
been
extensively
described
elsewhere,
subtypes
not.
Owing
to
its
multifaceted
nature,
this
review
proposes
characterises
six
based
existing
literature.
are
non‐severe
multi‐organ
sequelae
(NSC‐MOS),
pulmonary
fibrosis
(PFS),
myalgic
encephalomyelitis
chronic
fatigue
(ME/CFS),
postural
orthostatic
tachycardia
(POTS),
post‐intensive
care
(PICS)
medical
clinical
(MCS).
Original
studies
supporting
each
these
documented
review,
as
well
their
respective
potential
interventions.
Ultimately,
subtyping
proposed
herein
aims
provide
better
clarity
current
understanding
PCS.